PepDirekt™ is an independent TIC platform. We provide audit services only — we do not sell, manufacture, or distribute peptides. · Request Audit →
Operational Status: Live
| Accepting Audit Mandates for Q2 2026
5 Suppliers Audited
3 Factory Visits Done
2 Samples @ Janoshik
Active Field Mission ⚠ UNDER INTENSIVE REVIEW
Active Audit Status: Project #2026-04-CN
Our team is currently on the ground in Jiangsu, China. During the documentary forensic phase for a Tirzepatide batch mandate, we identified a critical P0 Data Mismatch — the HPLC metadata batch number does not align with the COA cover lot number. Physical site inspection and independent blind sampling are now underway.
⚠ P0: Lot Number Mismatch Detected 📄 Raw .lcd Metadata Requested 🧪 Independent Blind Sampling Active 🔒 Escrow Hold Advised
Last updated: April 27, 2026 · 11:05 CST · PepDirekt™ Field Intelligence
View Redacted Report Request Private Audit →
TIC Platform — Testing, Inspection & Certification

The auditor between you and the peptide supply chain

PepDirekt™ is an independent third-party TIC platform. We don't sell peptides. We don't manufacture. We don't store inventory. We verify — with legal rigor and scientific precision

Request Audit → 🔬 Live Audit Report

Not ready to talk? Download our 4-Step Audit Framework (PDF)

The Trust Triangle
Client — PepDirekt™ — Factory
Three-party structure that eliminates information asymmetry and aligns incentives for all parties.
Core Protocol
SOP-001: Supplier Onboarding
Pre-qualification questionnaire + Janoshik blind testing + field audit. No exceptions.
Operational Independence
No Commission. No Inventory. No Conflict.
We earn from consulting fees and factory access fees — never from product sales. This eliminates the incentive to pass a supplier that shouldn't pass.
12+ Suppliers Vetted (Q1 2026)
4 Critical Discrepancies Flagged
$150k+ Capital Secured via Escrow
< 48h Lab Report Turnaround
Service Tiers

Four Tiers
Zero Hidden Fees

Every tier includes the full audit protocol. The higher the tier, the more factories you can access and the more hands-on support you receive.

💬
Tier 1 · L1

Consult

One-time advisory session for clients evaluating their current supply chain or exploring sourcing options.

$500 – $1,500 Starting at

Independent audit services only. Not a pharmaceutical distributor.

  • 60-min strategy call
  • Current supplier risk assessment
  • Written summary report
  • Follow-up email Q&A
Request Quote →
🔍
Tier 2 · L2

Verify

Full supplier audit for one factory. Includes Janoshik testing coordination, field audit, and written report.

Independent audit services only. Not a pharmaceutical distributor.

  • Pre-qualification review
  • Janoshik blind testing
  • Field audit report
  • Pass / Reject verdict
  • 6-month re-test monitoring
Request Quote →
MOST POPULAR
🛡️
Tier 3 · L3

Escrow

Supply chain monitoring + transaction escrow service for ongoing client-factory relationships.

Independent audit services only. Not a pharmaceutical distributor.

  • Everything in Verify
  • Factory whitelist access
  • Batch documentation review
  • Escrow payment service
  • Monthly audit summary
Request Quote →
🏛️
Tier 4 · L4

Institutional

White-label audit service for clinics, pharmacies, or distributors sourcing from multiple factories.

Independent audit services only. Not a pharmaceutical distributor.

  • Everything in Escrow
  • Multi-factory management
  • API integration for reporting
  • Dedicated account manager
  • Quarterly board reports
Request Quote →

Comparing options? Download our Service & Audit Overview (PDF)

The Protocol

How PepDirekt™
Verifies a Supplier

Six-step audit process. No shortcuts. Every factory goes through the same rigorous evaluation before entering the whitelist.

🎯
Our Mission: Bridging the Gap

We don't just verify data; we ensure that the transparency expected by Western clients is strictly enforced at the source through legal and forensic rigor.

Anti-Doping Compliance

Every audit includes screening against the WADA Prohibited List (S1–S5 substance categories) — covering anabolic agents, peptide hormones, beta-2 agonists, hormone antagonists, and diuretics. Contaminants that would trigger a failed doping test are flagged before any batch reaches your organization.

◆ LC-MS/MS Quantitative Analysis — high-resolution mass spectrometry for trace-level contaminant detection
◆ HPLC Purity Profiling — independent verification of claimed purity percentages
◆ Contamination Panel — every report includes a full impurity profile with quantitative thresholds

Critical for sports management organizations and professional athletes subject to anti-doping regulations.

Regulatory Alignment

Audit protocols are designed with FDA 21 CFR Part 211 (current Good Manufacturing Practice), DEA scheduling considerations, and international import/export compliance in mind. All documentation produced is structured for legal defensibility.

◆ Attorney-supervised protocols — audit documentation designed for legal review
◆ Contractual risk allocation — standardized terms for supplier accountability
◆ Import/export documentation — compliance review for cross-border shipments

Applicable to clinics, compounding pharmacies, and institutional procurement teams.

SOP-001

Pre-Qualification

Supplier submits Pre-Qualification Questionnaire covering GMP certification, API capabilities, production scale, and compliance history. Incomplete submissions are rejected immediately.

SOP-002

Janoshik Blind Testing

Independent third-party lab (Janoshik) conducts purity and contamination testing on samples — with zero information shared about the supplier's identity. Results are unmanipulable.

SOP-003

Field Audit

On-site inspection of production facilities, quality control systems, and documentation trails. Photos, videos, and handwritten notes compiled into a Field Audit Report.

SOP-004

Report & Decision

Full audit report delivered to client with Pass / Conditional Pass / Reject rating. Rejected suppliers added to internal blacklist — not re-evaluated within 12 months.

SOP-005

Ongoing Monitoring

Approved suppliers subject to random re-testing every 6 months. Any deviation from previously passed results triggers an automatic re-audit.

SOP-006

Chain of Custody

Every batch tracked from production to delivery with timestamped documentation. Creates a legally defensible paper trail for clients in regulated environments.

SOP-001 in Action: Live Field Report.

Want to see how we catch documentation fraud? Download our latest Redacted Field Report — see our forensic process in action, from batch mismatch detection to physical site inspection.

Printable PDF · Share with your team or compliance officer

Download Redacted Report Or get the 4-Step Audit Framework →
Intelligence Hub

Live Audit Journal
& Case Archives

We publish our field findings publicly. No vendor name-calling — just facts. This is what "Building in Public" means for supply chain integrity.

🔬 Live Case: Batch Mismatch Forensic Analysis — Project #2026-04-CN

Last updated: April 27, 2026, 11:05 CST · REDACTED / CONFIDENTIAL
PepDirekt Forensic Analysis: Vendor COA vs. PepDirekt Findings
💡 Why this matters: Most buyers receive the document on the left — a polished, compliant-looking COA with no visible red flags. PepDirekt's forensic review caught the critical discrepancy on the right: the HPLC metadata batch number (JT-185***) does not match the COA cover lot number (JT-202***). This finding triggered SOP-001 and initiated an immediate Escrow hold.
PepDirekt Audit Report
Project #2026-04-CN April 2026 · Jiangsu Bio-cluster
⚠ CAUTION — UNDER INTENSIVE REVIEW

Tirzepatide & Retatrutide Batch Validation — Documentary Forensic Phase

Mandated by a US-based clinical client. Objective: verify clinical-grade integrity and ensure total physical traceability from source. Our documentary forensic phase has identified three critical risk indicators prior to physical site entry.

Forensic Findings

  • ⚠

    [P0 CRITICAL] Data Integrity Mismatch

    Tirzepatide HPLC raw chromatogram metadata batch number (JT-185***) does not match COA cover page lot number (JT-202***). This is a classic "Template Recycling" indicator — the analytical data may not have been generated from the specific batch offered for sale. SOP-001 triggered.

  • 📄

    [TECHNICAL GAP] Absence of Raw .lcd Metadata

    Vendor currently provides static PDF only. PepDirekt has issued a formal demand for HPLC workstation raw metadata files (.lcd/.org). Without original timestamps and manual integration logs, finality of reported purity levels cannot be certified.

  • ⚖️

    [QUALITY OBSERVATION] Peptide Content Variance

    While nominal purity is high, actual Peptide Content hovers near the lower compliance threshold (≈95%). This indicates a potential 5% dosage variance during clinical formulation — escalated to client's procurement risk profile.

Audit Timeline

✓
SOP-001
Pre-Qualification
✓
SOP-002
COA Forensic Review
▶
SOP-003
Site Inspection
3
SOP-004
Report & Verdict
5
SOP-005/006
Monitoring · CoC
Location: Jiangsu, China (Nanjing/Suzhou region)  |  Substances: Tirzepatide, Retatrutide  |  Status: Under Intensive Review
Download Redacted Report Request Private Audit →

Archived Cases

🔬 March 2026 · Factory Audit

2026 Q1 Peptide Factory Whitelist — 12 Suppliers Evaluated

Blind testing results for 12 Chinese factories across BPC-157, TB-500, and GHK-Cu product lines. Purity ranges from 95.2% to 99.8%. Full lab reports included.

Read Full Report →
📊 March 2026 · Market Analysis

Supply Chain Risk Report: Contamination Rates in Off-Label Peptide Products

Analysis of 47 third-party lab tests conducted in 2025. Endotoxin and microbial contamination found in 23% of samples from non-audited suppliers. Critical reading for procurement teams.

Read Full Report →
Business Model

The Trust Triangle

Three parties, one protocol. PepDirekt™ sits at the center and aligns incentives across the entire supply chain.

🎯
Principal

Client

Who: High-net-worth individuals, professional sports management teams, clinics.

Wants: Certainty, compliance, clean paper trail, zero liability.

Gets: Audit report, supplier match, supply chain oversight.

🔍
Auditor

PepDirekt™

Who: US-Licensed Legal Counsel & Audit Team.

Does: Supplier pre-qualification, Janoshik coordination, attorney-supervised audit reporting, risk allocation.

🌉  Attorney-supervised audit protocols. Work product protections apply.

Earns: Consulting fees + factory access fees + data subscriptions.

🏗️
Supplier

Factory

Who: GMP-certified Chinese API manufacturers.

Wants: Premium client access, brand credibility, recurring volume.

Needs: Passing the PepDirekt™ audit to enter the whitelist.

Supply Chain Intelligence

The Factory Whitelist

Every factory in the whitelist has been through the full audit. This is not a directory — it's a curated selection of pre-vetted partners.

🏭

GMP-Certified API Manufacturers

Production facilities with valid GMP certification, clean room specifications, and QC documentation meeting US FDA 21 CFR Part 211 standards.

🧪

Janoshik-Tested Purity

All listed factories have completed at least one round of independent blind testing via Janoshik Analytical, with purity scores above 98% on primary target peptides.

📋

Audit Trail Documents

Complete Field Audit Reports available on request. Includes facility photos, process documentation, and Chain of Custody protocols for every tested batch.

🔒

Client Isolation

Supplier performance data is never shared between clients. Each client relationship is siloed — factories don't know who your clients are.

⚡

Blind Testing Protocol

Janoshik receives samples without supplier identification. Lab results cannot be manipulated post-testing. The protocol is designed to be tamper-proof.

📈

Ongoing Monitoring

Random re-testing every 6 months for all approved factories. A single failed re-test triggers immediate suspension pending full re-audit.

Transparent Fee Schedule

Audit Service
Fee Schedule

No hidden fees. No commissions on product sales. You pay for the audit — nothing else.

Consult Verify Escrow Institutional
Investment Request Quote → Request Quote → Request Quote → Request Quote →
Strategy Call ✓ ✓ ✓ ✓
Supplier Risk Assessment ✓ ✓ ✓ ✓
Janoshik Blind Testing — ✓ ✓ ✓
Field Audit Report — ✓ ✓ ✓
Factory Whitelist Access — — ✓ ✓
Escrow Payment Service — — ✓ ✓
Batch Documentation Review — — ✓ ✓
Monthly Audit Summary — — ✓ ✓
Dedicated Account Manager — — — ✓
Quarterly Board Reports — — — ✓
6-Month Re-Test Monitoring — ✓ ✓ ✓
Case Briefs

Risk Mitigation
In Action

Real scenarios from our audit pipeline. Client identities protected. Facts speak louder than testimonials.

Intercepted

A West Coast longevity clinic was preparing a $50,000 order of Tirzepatide from a previously "verified" supplier. Our field audit revealed incomplete cold chain documentation and a 15% discrepancy between self-reported and independently tested purity. The order was redirected to a PepDirekt™-verified alternative.

Purity Discrepancy Detected March 2026 · Tirzepatide · Yangtze River Delta
$50k Risk Avoided

Bottom Line: Without this audit, $50,000 of potentially adulterated product would have been administered to patients — exposing the clinic to malpractice liability and FDA investigation.

Verified

A sports management organization required anti-doping compliance documentation for a multi-peptide procurement. Our audit identified 4% unknown impurities in a Retatrutide batch via Janoshik blind testing — contaminants that would have triggered a failed WADA screening. The supplier was rejected before any commitment was made.

WADA-Prohibited Contaminants Found February 2026 · Retatrutide · Suzhou BioBAY
Compliance Secured

Bottom Line: These contaminants would have triggered a failed WADA doping test — resulting in athlete suspensions, organizational sanctions, and irreversible reputational damage.

Verified

A compounding pharmacy in the Southeast was sourcing BPC-157 from two factories. Our dual-factory audit revealed that one supplier had been recycling HPLC data across batches — a documentation fraud that would have been invisible without on-site inspection. Chain of Custody documentation was established from that point forward.

Documentation Fraud Uncovered January 2026 · BPC-157 · Dual-Factory Audit
CofC Established

Bottom Line: The pharmacy was unknowingly distributing products with fabricated lab data — a criminal risk invisible without on-site forensic inspection.

Intercepted

A Midwest pharmacy group planned to onboard a new Semaglutide supplier offering "FDA-registered facility" documentation. Our pre-qualification review found the facility registration had expired 14 months prior, and the factory had received an FDA Form 483 citation that was never disclosed. Supplier was blacklisted pending re-audit.

Expired FDA Registration + Undisclosed 483 December 2025 · Semaglutide · Pre-Qualification
Blacklisted

Bottom Line: An undisclosed FDA Form 483 is a material compliance failure. Onboarding this supplier would have exposed the pharmacy group to regulatory enforcement and supply chain shutdown.

Lead Auditor's Notes

From the
Field Desk

On-the-record commentary from our audit team. No marketing copy — just what we're seeing on the ground.

🎙 Lead Auditor Statement
"A PDF report is a claim, not a guarantee. This week's finding of a Lot Number mismatch — JT-202*** on the cover versus JT-185*** embedded in the HPLC metadata — proves exactly why forensic oversight at the point of origin is non-negotiable. We protect your patients and your capital by deconstructing 'perfect' documents."
👨‍⚖️
Lead Auditor, PepDirekt™
PepDirekt TIC Platform · Project #2026-04-CN
Filed: April 27, 2026 · Jiangsu, China
Request a Private Audit Mandate
Ready to secure your next procurement? Speak with our team before committing capital.
Average response time: < 24 hours · US-based support
SOP-001 in Action

Currently performing forensic analysis on raw metadata for a Tirzepatide mandate. Our protocol successfully flagged a "Template Recycling" risk before capital was committed — exactly the scenario our SOP was designed to catch.

Building in Public

We publish our findings because transparency is our competitive advantage. Clients who understand why an audit matters make better procurement decisions. That's the value of working with PepDirekt — you know the risks before your competitors do.

Get Started

Request an Audit

Tell us about your sourcing needs. We'll respond within 24 hours with a preliminary assessment and next steps.

info@PepDirekt™ @PepDirekt™
⚠ By submitting this form, you acknowledge that PepDirekt™ is an audit and advisory service only. We do not sell, manufacture, store, or distribute any peptide products. All inquiries are reviewed for compliance before response.